审查当前的指导方针和创新在良性前列腺增生症的评估和管理
Jaspreet S Sandhu1, Felix Cheung2
1Department of Surgery/Urology, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, 353 East 68th Street, New York, NY 10065, USA.
The Urologic clinics of North America
|October 17, 2025
概括
本综述涵盖了最新的良性前列腺增生症 (BPH) 管理策略,包括新的诊断工具,如AI和各种手术选择. 它强调个性化治疗方法,以获得最佳的患者结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗技术 医疗技术 医学技术
背景情况:
- 良性前列腺增生 (BPH) 是一种常见的疾病,影响老年男性.
- 目前的BPH管理涉及一系列的治疗方法,但不断出现的进展.
研究的目的:
- 审查最近BPH评估和管理方面的进展.
- 要突出2023年美国泌尿学会指南的更新.
- 讨论新出现的诊断和治疗方式.
主要方法:
- 综合性文献审查,重点关注最近的研究和指导方针.
- 对诊断方法的分析,包括临床评估,成像,人工智能和机器学习.
- 手术干预的分类,从微创手术到绝对手术.
主要成果:
- 建议采用个性化的算法诊断方法.
- 手术的选择范围从前列腺尿道提升和水蒸气疗法到荷激光核和机器人前列腺切除.
- 人工智能和机器学习在诊断中显示出新兴的角色.
结论:
- 在BPH的管理需要基于最新证据的个性化方法.
- 有一系列的手术治疗,以满足个体患者的需求.
- 未来的BPH护理可能会涉及新的治疗方法,精准医学和成本效益分析.
相关概念视频
Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
Urinary Tract Calculi III: Medical Management
193
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
193
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
250
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
250
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
554
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
554
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
371
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
371
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
457
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
457


